Internal Medicine, Hematology & Oncology · Mayaguez, PR
NPI
1659481323
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Calle Morel Campos #4
Mayaguez, PR, 00680
Phone (787) 832-0040
Medicare paid, 2024
$25K
1,206 services
Medicare patients, 2024
13
Average age 74
Drug cost, 2024
$3.8M
2,676 prescriptions
Company payments, 2025
$473
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Sifredo Acaron III prescribed most often to Medicare patients was Anastrozole, with 137 prescriptions and refills. In total Sifredo Acaron III wrote 2,676 Medicare prescriptions that cost $3.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 137 | 183 | 24 | $2,390 |
| Warfarin Sodium Generic | 115 | 125 | 14 | $978 |
| Losartan Potassium Generic | 105 | 115 | 29 | $700 |
| Nifedipine Er Nifedipine | 101 | 114 | 24 | $1,647 |
| Lisinopril Generic | 101 | 115 | 21 | $378 |
| Prednisone Generic | 94 | 94 | 17 | $694 |
| Acyclovir Generic | 83 | 85 | 19 | $1,343 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 72 | 72 | 18 | $2,089 |
| Famotidine Generic | 66 | 68 | 28 | $365 |
| Ondansetron Hcl Generic | 64 | 64 | 29 | $359 |
| Levothyroxine Sodium Generic | 64 | 72 | 15 | $489 |
| Revlimid Lenalidomide | 58 | 58 | 11 | $1.1M |
| Hydroxyurea Generic | 57 | 61 | Under 11 | $1,681 |
| Spironolactone Generic | 55 | 67 | 21 | $805 |
| Furosemide Generic | 54 | 62 | 22 | $249 |
Brand drugs: - claims; generic drugs: 2,200 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sifredo Acaron III $473 ($473 in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Biotech, Inc. with $200.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.